002800 (002800) Fair Value & Analysis
Healthcare · Market cap 70.2B KRW
Fair value as of: Jun 25, 2026
From 24 valuation models · updated 7 days ago
Share price −8.9% over the past month.
Price vs Fair Value (12 months)
12‑month range 3,992 KRW – 6,389 KRW · fair‑value band 6,085 KRW – 10,719 KRW · the 4,260 KRW price screens below the 8,575 KRW fair value. As of Jun 25, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
002800 (002800) currently trades at 4,260 KRW, while our model-based Fair Value estimate is 8,575 KRW — implying the stock looks roughly 101.3% undervalued today. We read business quality at 53/100 (solid quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.
Over the trailing twelve months, 002800 generated revenue of 119B KRW at a net margin of 9.4%. Revenue grew 19.2% year over year. It earns a return on equity of 15.6%. Net debt stands at 39.6B KRW. Fundamentals as of Jun 25, 2026
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jun 25, 2026. TTM = trailing twelve months.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
002800 reported revenue of 114B KRW in FY2025 versus 74.0B KRW in FY2021, a compound +11.4%/yr. Reported net income was 9.3B KRW in FY2025.
Is 002800 fairly valued? → Check now
Similar stocks
6 more Drug Manufacturers - Specialty & Generic stocks, each showing price versus our Fair Value estimate (as of Jun 25, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| 1276 1276 | HK$57.85 | HK$29.84 | -48% |
| Jiangsu Hengrui Pharmaceuticals Co 600276 | ¥47.08 | ¥26.59 | -44% |
| Sun Pharmaceutical Industries Limited SUNPHARMA | ₹1,786 | ₹991.46 | -44% |
| Zoetis Inc Z1TS34 | R$25.93 | R$19.70 | -24% |
| Hansoh Pharmaceutical Group 3692 | HK$29.30 | HK$23.90 | -18% |
| Divi's Laboratories Limited DIVISLAB | ₹6,639 | ₹1,281 | -81% |
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is 002800 (002800) undervalued?
What is the fair value of 002800?
What is the quality score of 002800?
What is the revenue of 002800 (002800)?
What is the net profit margin of 002800?
Does 002800 pay a dividend?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.